Connor, Clark & Lunn Investment Management (CC&L)’s aTyr Pharma ATYR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-3,150
| Closed | -$117K | – | 1114 |
|
|
2018
Q1 | $117K | Hold |
3,150
| – | – | ﹤0.01% | 685 |
|
|
2017
Q4 | $154K | Hold |
3,150
| – | – | ﹤0.01% | 737 |
|
|
2017
Q3 | $223K | Hold |
3,150
| – | – | ﹤0.01% | 745 |
|
|
2017
Q2 | $152K | Buy |
3,150
+71
| +2% | +$3.43K | ﹤0.01% | 766 |
|
|
2017
Q1 | $151K | Buy |
3,079
+350
| +13% | +$17.2K | ﹤0.01% | 825 |
|
|
2016
Q4 | $82K | Buy |
2,729
+186
| +7% | +$5.59K | ﹤0.01% | 846 |
|
|
2016
Q3 | $113K | Buy |
2,543
+1,693
| +199% | +$75.2K | ﹤0.01% | 770 |
|
|
2016
Q2 | $33K | Buy |
+850
| New | +$33K | ﹤0.01% | 845 |
|